返回
Swedish Orphan Biovitrum AB (publ) (BIOVF) 財務
BIOVF 股價走勢圖
BIOVF 財務
Swedish Orphan Biovitrum AB (publ)
$41.32
0%
$0
收盤價：Mar 26, 16:00:00 GMT-4
$41.32
0%
$0
盤前：Mar 27, 04:14:51 GMT-4
關鍵數據
前收市價
$41.32
開盤價
$41.32
當日範圍
$41.32 - $41.32
52週區間
$25.79 - $42.21
交易量
100
平均成交量
15
股息收益率
--
每股盈餘 (TTM)
0.15
市值
$14.7B
什麼是 SWEDISH ORPHAN BIOVITRUM AB？
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Stockholm, Stockholm and currently employs 1,888 full-time employees. The company went IPO on 2006-09-15. The firm develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company’s product portfolio is divided into three business segments: the Core Products segment offers pharmaceuticals within Inflammation area, and Genetics and metabolic therapeutic area; the Partner Products segment offers about 40 pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The firm has subsidiaries in Sweden, Denmark, Finland, Norway, United Kingdom and France, among others.